Peer support boosted Hepatitis C treatment access among marginalised populations in England: A Bayesian causal factor analysis.

A Bayesian causal factor analysis of England's National Health Service Hepatitis C programme reveals that implementing country-wide peer support significantly increased case identification and promoted equitable treatment access among marginalized populations, particularly during the initial COVID-19 lockdown.

The Gist

Imagine the fight against Hepatitis C (a virus that damages the liver) as a massive game of hide-and-seek. The "seekers" are the doctors and the National Health Service (NHS), and the "hiders" are the people infected with the virus who, for various reasons, are hard to find or afraid to ask for help.

For years, the game was tough. The people hiding the most were often those on the fringes of society: people who use drugs, those experiencing homelessness, or people who have been in prison. Traditional doctors often couldn't reach them because these groups didn't trust the system or didn't know where to go.

The New Strategy: The "Peer" Guides
To solve this, England tried something different. Instead of just sending more doctors, they hired "Peer Support Workers."

Think of these peers as veteran guides who have already walked the path. They are people who used to be infected with Hepatitis C, or who have lived through homelessness or addiction, but who have now recovered and are healthy. Because they have "been there, done that," they speak the same language as the people they are trying to help. They aren't just medical staff; they are neighbors, friends, and mentors who understand the struggles of the community.

The Experiment: A Staggered Rollout
The researchers wanted to know: Do these guides actually work?

They couldn't just test this everywhere at once because there weren't enough guides to go around. So, they played a game of "Staggered Start." Imagine 22 different towns (called Operation Delivery Networks). They introduced the guides to Town A in early 2018, then Town B in mid-2018, then Town C later, and so on.

This allowed the researchers to compare the towns that had guides against the towns that didn't yet have them, acting like a natural experiment. They used a sophisticated statistical "time machine" (called a Bayesian causal factor analysis) to predict what would have happened in the towns with guides if the guides hadn't been there, and then compared that prediction to reality.

The Results: Finding the Hidden
The study looked at data from 2016 to 2021 and found some amazing results:

1. More People Found: The towns with peer guides found 14% more people with Hepatitis C than they would have otherwise. That's like finding an extra 2,200 people who were previously invisible to the healthcare system.
2. More People Cured: These guides helped more people actually finish their treatment and get cured (a "sustained viral response").
3. The "Lockdown" Superpower: Interestingly, the guides were even more effective during the first COVID-19 lockdown. When regular hospitals were closed or overwhelmed, and people were isolated, the peers were often the only link these vulnerable people had to healthcare. They kept the line open when everything else was shut down.

The "Training Wheels" Effect
The study also noticed something interesting about how the guides worked. It wasn't instant magic.

• The First Few Months: When a guide first arrived in a town, nothing much happened. It took about 8 months for them to build trust, learn the ropes, and make connections.
• The Sweet Spot: Between 8 and 18 months, the results skyrocketed. The guides were fully integrated, and the community was trusting them.
• The Plateau: After about 18 months, the growth slowed down a bit. This makes sense: the guides had already found the people who were easiest to reach. The remaining people were the hardest to find, requiring even more effort.

Why This Matters
This study proves that empathy is a powerful medicine. By hiring people with lived experience to help others, England didn't just treat a virus; it bridged a gap between the healthcare system and the people who needed it most.

The researchers concluded that if we want to eliminate Hepatitis C completely, we need to keep hiring these peer guides. They are the key to unlocking the doors that traditional medicine often can't open, ensuring that no one is left behind in the fight for health.

In a Nutshell:

• The Problem: Sick people were hiding because they didn't trust doctors.
• The Solution: Hire people who were sick and are now healthy to go find them.
• The Result: It worked. More people were found, more were cured, and it worked especially well when the world was in crisis.
• The Lesson: Sometimes, the best way to heal a community is to let the community heal itself.

Technical Summary

1. Problem Statement and Context

The Challenge: Hepatitis C virus (HCV) disproportionately affects marginalised populations, particularly people who inject drugs (PWID), those experiencing homelessness, and individuals with a history of incarceration. These groups are often excluded from traditional healthcare services, creating significant barriers to diagnosis and treatment. Despite the availability of highly effective Direct-Acting Antiviral (DAA) treatments, achieving the World Health Organization's (WHO) 2030 elimination targets requires equitable access to care.

The Intervention: In 2018, NHS England (NHSE) launched a country-wide peer support programme. Peer support workers ("peers") are individuals with lived experience of HCV and/or marginalisation (e.g., drug use, homelessness) who facilitate testing, treatment navigation, and engagement. The intervention was rolled out in a staggered manner across 22 Operation Delivery Networks (ODNs) to manage capacity, creating a natural quasi-experimental setting.

The Gap: Previous evidence on peer support for HCV was limited to small-scale Randomised Controlled Trials (RCTs) or short-term observational studies. There was a lack of robust, long-term, national-scale evidence quantifying the causal impact of peer support on key epidemiological outcomes, specifically case identification (finding new cases), treatment completion, and engagement of the most marginalised groups.

2. Methodology

The study employed a rigorous Bayesian causal factor analysis to estimate the causal effects of the peer intervention, leveraging the staggered rollout as a natural experiment.

• Data Sources:

  • Blueteq: A high-cost drug system database used for treatment funding requests. It served as an exhaustive record of identified HCV cases (Primary Outcome).
  • The Registry: A secure online system containing detailed patient data (demographics, treatment history, referral sources). Used for Secondary Outcomes: Sustained Viral Response (SVR) and Drug Service Referrals.
  • HCT Database: Provided data on peer activities, including start dates, locations, and characteristics of individuals supported.
  • Timeframe: June 2016 to May 2021 (pre- and post-intervention).

• Statistical Model:

  • Framework: A Bayesian potential outcomes framework.
  • Distribution: Outcomes were modeled using a Negative Binomial distribution to handle overdispersion common in count data.
  • Counterfactual Construction: The model imputed "intervention-free" counterfactuals (what would have happened without peers) for post-intervention periods.
  • Model Components:
    1. ODN-specific intercepts: Controlled for time-constant differences between regions (e.g., capacity/willingness to adopt peers).
    2. Time-fixed effects: Adjusted for temporal trends common to all ODNs (e.g., general changes in HCV prevalence).
    3. Interactive fixed effects: Accounted for time-varying unmeasured confounders specific to each ODN.
    4. Intervention Term: Modeled the impact of peers as a function of cumulative peer-months (exposure intensity) and the presence of the COVID-19 lockdown.
  • Relaxation of Assumptions: Unlike standard Difference-in-Differences (DiD) methods, this approach relaxes the "parallel trends" assumption by allowing for time-varying unobserved confounders.
  • Inference: Parameters were estimated using Markov Chain Monte Carlo (MCMC) via the rstan library. Results are presented as posterior means with 95% Credible Intervals (CrI) and Posterior Probabilities of a positive effect (PPos).

• Outcomes Measured:

  1. HCV Cases Identified: Number of new individuals confirmed as HCV positive (Primary).
  2. Sustained Viral Response (SVR): Number of patients achieving cure.
  3. Drug Service Referrals: Number of patients initiating treatment referred specifically from drug services.

3. Key Contributions

1. First National-Scale Causal Evaluation: This is the first study to evaluate the long-term, country-wide impact of peer support on HCV case identification, a critical but previously unmeasured outcome.
2. Advanced Causal Inference: The application of a Bayesian causal factor model allows for robust inference in a non-randomised, staggered adoption setting, effectively mitigating confounding bias without requiring a randomised trial.
3. Heterogeneity Analysis: The study uniquely models the non-linear relationship between intervention intensity (peer-months) and outcomes, identifying a "ramp-up" period and a plateau effect.
4. Crisis Context: It provides evidence on the efficacy of peer support during the COVID-19 lockdown, a period where traditional health services were severely disrupted.
5. Focus on Marginalisation: By linking intervention data with patient demographics, the study confirms that peers successfully engaged populations traditionally excluded from care (PWID, homeless).

4. Key Results

• Overall Impact (June 2016 – May 2021):

  • Case Identification: Peers increased the number of identified HCV cases by 13.9% (95% CrI [5.3, 21.7]; PPos = 99.8%). This corresponds to approximately 2,166 additional individuals identified.
  • Sustained Viral Response (SVR): Increased by 8.0% (95% CrI [–4.4, 18.6]; PPos = 91.1%).
  • Drug Service Referrals: Increased by 8.8% (95% CrI [–12.5, 22.6]; PPos = 84.2%).

• Impact During COVID-19 Lockdown (March–May 2020):

  • The effectiveness of the intervention was significantly magnified during the first national lockdown.
  • Case Identification: Increased by 34.8% (95% CrI [19.4, 48.1]; PPos > 99.9%).
  • SVR: Increased by 28.2% (95% CrI [4.0, 46.3]; PPos = 98.7%).
  • Drug Service Referrals: Increased by 31.1% (95% CrI [6.4, 50.8]; PPos = 99.3%).

• Exposure Intensity (Dose-Response):

  • The relationship between peer-months and outcomes is non-linear.
  • 0–8 peer-months: No significant effect (likely due to training and network establishment time).
  • 8–18 peer-months: Sharp increase in effectiveness.
  • >18 peer-months: Effects plateau but remain positive.

• Demographics:

  • Individuals supported by peers were predominantly from marginalised groups: 34.6% were current injectors, 58.6% were past injectors, and 17.6% were experiencing homelessness.

5. Significance and Policy Implications

• Equity in Healthcare: The study demonstrates that peer support is a highly effective mechanism for reducing health disparities, successfully reaching populations that traditional NHS services fail to engage.
• WHO Elimination Targets: The findings provide strong evidence that sustaining and scaling peer support programmes is essential for meeting the WHO's 2030 HCV elimination goals.
• Crisis Resilience: The amplified effect during the COVID-19 lockdown suggests that peer networks are critical for maintaining healthcare access when formal clinical services are constrained. This supports the recruitment of peers as a strategy for future public health emergencies.
• Implementation Strategy: The non-linear dose-response relationship suggests that a "ramp-up" period is necessary before full benefits are realized. Policymakers should account for this lag when evaluating new interventions and consider optimal rollout strategies to maximize cost-effectiveness.

Conclusion: The study provides robust, causal evidence that a national peer support programme significantly improves HCV case finding and treatment access in England, particularly for the most marginalised populations and during public health crises. It validates the peer support model as a cornerstone strategy for HCV elimination.